Everybody knows the current clinical trial model is broken. But it’s not technology that will fix it – it’s a mindset shift towards seeing clinical trials through the ‘user’s’ eyes.
To what extent is patient engagement really valued and acted upon by pharma companies, CROs and hospitals – and what are the most effective methods to retain participants in clinical trials?
The capabilities of artificial intelligence are advancing and its 'third wave' offers the ability to analyse enormous sets of data, identify patterns, and generate algorithms to explain them, t
If clinical trial results were more quickly and openly accessible, medical improvements would be implemented more swiftly too. So what can be done to ease this process?